2016 Annual Meeting | Multiple Sclerosis Therapy: Symptom Management
| 01:00 PM - 01:30 PM |
Management of Spasticity, Fatigue, and Sleep Disorders in MS
Jonathan L. Carter, MD |
|
| 01:30 PM - 02:00 PM |
Management of Ambulatory Dysfunction in MS
Michelle Cameron, MD |
|
| 02:00 PM - 02:30 PM |
Management of GU Dysfunction: When MS Hits Below the Belt
Barbara S. Giesser, MD, FAAN |
|
| 02:30 PM - 03:00 PM |
Case-Based Panel Discussion: MS Symptom Management
|
| Jonathan L. Carter, MD | Dr. Carter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck Pharmaceuticals A/S. The institution of Dr. Carter has received research support from MedDay Pharmaceuticals . The institution of Dr. Carter has received research support from Roche Pharmaceuticals. |
| Barbara S. Giesser, MD, FAAN | Dr. Giesser has received publishing royalties from a publication relating to health care. Dr. Giesser has a non-compensated relationship as a advisory committee member with National MS Society that is relevant to AAN interests or activities. |
| Michelle Cameron, MD | Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich Biosciences/Jazz . Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharmaceuticals. Dr. Cameron has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Cameron has received research support from National MS Society. The institution of Dr. Cameron has received research support from Department of Veterans Affairs. Dr. Cameron has received publishing royalties from a publication relating to health care. |